erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims. .
OFF DEAL
OFF DEAL
OFF DEAL
200 Used Today